Biomedical Research Group


Our Biomedical Research Group aims to integrate research into the genotypic and phenotypic relationships underpinning our understanding of health and disease.

We're a diverse research group with interests in biochemical and molecular mechanisms that underpin the pathogenesis and aetiology of mammalian diseases, such as rheumatoid arthritis, myeloproliferative diseases, inflammation, thrombosis, tumorigenesis, vascular injury, and diabetes. Additionally, we have interests in G-protein coupled receptor signalling, the genetics of antibiotic resistance, virulence and evolution of bacteria.

The Biomedical Research Group is located in ARU's Science Centre, a £45m state-of-the-art teaching and research facility. Included in the centre are dedicated research laboratories with space for more than 50 staff and postgraduate students, providing specialist tissue culture, molecular biology and microbiology research spaces. The centre incorporates a 300-seat lecture theatre adapted for science teaching and a 200-station biosciences laboratory.

If you're part of an organisation, biomedical science provider, or research group who wishes to collaborate or explore possible areas of research our specialisms might support, then please contact a member of the group or our Deputy Head of Department for Research, Dr Nicholas Pugh, at

We offer our Biomedical Science PhD, and a range of innovative research project opportunities for postgraduate researchers.

Headed by Dr Peter Coussons, the Biomedical Research Group is grouped into several specialist research areas which include:


Find out more about our members on their profile pages.


Funding awarded for collaborative project in School of Life Sciences

Hollie Allison and Katie Choi, biomedical science students at our University, have both received a £2,000 summer studentship from the Wellcome Trust. Hollie is isolating and identifying antibiotic-resistant strains of bacteria from dog faeces found in recreational areas of Cambridge. Katie Choi is working on the development of novel therapeutics against antibiotic resistance.